AD-driven MCI aAB biomarkers are capable of identifying preclinical AD pathology in otherwise cognitively normal (CDR = 0) STRIDE patients.
收藏Figshare2019-11-15 更新2026-04-29 收录
下载链接：
https://figshare.com/articles/dataset/AD-driven_MCI_aAB_biomarkers_are_capable_of_identifying_preclinical_AD_pathology_in_otherwise_cognitively_normal_CDR_0_STRIDE_patients_/10313306
下载链接
链接失效反馈官方服务：
资源简介：
AD-driven MCI aAB biomarkers are capable of identifying preclinical AD pathology in otherwise cognitively normal (CDR = 0) STRIDE patients.
创建时间：
2019-11-15
